NSPH, ABM, JAZZ, – PennyToBuck.com Watch List For Tuesday September 20th
pennytobuck Newsletter
__ ABM, ABM Industries Inc.
** Ampco System Parking, a subsidiary of ABM, has been awarded a multi-year contract to manage parking operations at Missouris Lambert-St. Louis International Airport.
Ranked as the 30th busiest airport in the U.S. by Airports Council International North America, Lambert-St. Louis International Airport served more than 12 million passengers in 2010.
ABM, which operates through its subsidiaries, is a leading provider of integrated facility services in the United States.
More about ABM at www.abm.com *********************
JAZZ, Jazz Pharmaceuticals, Inc.
** JAZZ and Azur Pharma Limited have agreed to combine to form Jazz Pharmaceuticals plc.
According to JAZZ, the combined company would have a diversified product portfolio, strong cash flow and expected annual revenues of more than $475 million.
JAZZ is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry.
More about JAZZ at www.jazzpharmaceuticals.com.
*********************
NSPH, Nanosphere, Inc.
** NSPH reported that its Verigene BC-GP test demonstrated 100% sensitivity and specificity for detection of the drug-resistant bacteria MRSA and VRE, and an overall sensitivity of 98.4% for a broad panel of bacterial targets.
Early laboratory identification of pathogenic bacteria in patients with bloodstream infections is critical to managing infections and improving patient outcomes. The benefits of faster diagnosis are well established and include increased survival rates, lower costs of patient care, and reduced use of unnecessary antibiotics.
The automated BC-GP test returns results for 13 bacterial identification targets and 3 antibiotic resistance targets in under two and a half hours as compared with current microbiological culture methods that can take 24 — 48 hours to identify bacterial pathogens and determine their resistance or susceptibility to common antibiotics.
This test is currently for investigational use only and not for clinical diagnostic use; the performance characteristics of the test have not been established. The BC-GP test is currently pending CE-IVD and FDA review and clearance.
NSPH is using the power of nanotechnology to create innovative molecular diagnostics for the medical field. The Verigene(R) System is an easy-to-use cartridge-based platform that enables rapid, cost-effective, multiplexed testing in a near-patient setting.
More about NSPH at www.nanosphere.us ********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
— The following information is a reminder of your current mailing list subscription:
You are subscribed to the following list:
pennytobuck.com
Related posts:
- NSPH, ABM, JAZZ, – CRWEWallStreet.com Watch List For Tuesday September 20th
- ABM, NSPH, JAZZ, – DoubleInStocks.com Stock Watch For Tuesday September 20th
- Study Predicts Heart Failure Deterioration – Stock News Report! – 12/17/2010
- Study Predicts Heart Failure Deterioration – Stock News Report! – 12/17/2010
- OCLS, NHPR – Stock Market Highlight by PennyToBuck.com